A new project, co-funded with EUR8.5m from the European Commission is underway to accelerate the development of new vaccines, drugs and microbicides to fight against many poverty-related diseases such as tuberculosis (TB), HIV, malaria, ...
Tags: Poverty Related Diseases, Medicine
Anti-malarial treatments that act on a new target have the potential to cure, prevent and block the transmission of the disease, U.S. researchers said. The as-yet undeveloped treatments would target an enzyme essential for the growth and ...
Tags: Anti-malarial, treatment, act, target, parasite
Mosquitoes are on the rise this summer, and several cases of West Nile virus infections from mosquitoes have been reported in Texas along with a few deaths. Other states have reported cases of West Nile virus infections as well. After ...
Coconuts are a versatile superfood providing nutrition, health benefits, and amazing medicinal properties all wrapped in one delicious package. Coconuts are totally natural, easily available and affordable; and every part of the fruit is ...
Tags: reason, coconut, home remedy, health, naturally
The health of most of the planet’s population is rapidly coming to resemble that of the United States, where death in childhood is rare, too much food is a bigger problem than too little, and life is long and often darkened by ...
Tags: Burden of Disease
Ranbaxy Laboratories has secured approval from India's Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell 'Synriam' to treat uncomplicated malaria caused by Plasmodium vivax parasite in adult patients. Phase III ...
Tags: Ranbaxy Laboratories, Drug Synriam
Luminex, a biotechnology company, has obtained the US Food and Drug Administration (FDA) and European approvals for a new personalized medicine genotyping assay, xTAG CYP2C19 kit. xTAG CYP2C19 kit is a comprehensive genotyping assay that ...
Tags: Genotyping Assay, Luminex
Luminex has received approvals from the US Food and Drug Administration (FDA) and EU authorities for the new version of xTAG CYP2D6 (Cytochrome P450 2D6) Kit. An IVD assay, the xTAG CYP2D6 Kit analyses a patient's CYP2D6 genotype from ...
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases. The funding will move the early-stage research to ...
Tags: Glaxosmithkline, funding injection
The Vaccine World Summit India 2013 conference has honored Novavax, Cadila Pharmaceuticals Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) collaboration for having the 'most promising ...
Tags: malaria vaccine, Pharmaceuticals, Vaccine
Diagnosing diseases such as malaria and tuberculosis in the developing world could be radically improved by a sensor attached to a mobile phone being developed by Australian researchers. Leader of CSIRO's Medical Devices Stream, Scott ...
Tags: mobile phone, tuberculosis, phone-attached miniature sensor
The Malawi orphanage funded by the Toy Trust's Three Peaks Challenge last year has now been built. The UK toy industry's charity arm has revealed to ToyNews that the orphanage - named Toy Trust House - will be home to over 50 children ...
Soil pollution is defined as the build-up in soils of persistent toxic compounds, chemicals, salts, radioactive materials, or disease causing agents, which have adverse effects on plant growth and animal health. The wars that hit the ...
Tags: Glass Industry, Soil Pollution, persistent toxic compounds, chemicals
NovaDel Pharma has signed a preliminary agreement to sell its NovaMist technology to SUDA, Australia-based pharmaceutical company. The acquisition, which includes the sale of NovaDel's patents and trademarks relating to NovaMist ...
Tags: NovaDel Pharma, acquisition, commercial terms, SUDA